Efficacy of cognitive behavioral therapy using self-check sheet for patients with nocturia in real-world clinical practice.


Journal

Lower urinary tract symptoms
ISSN: 1757-5672
Titre abrégé: Low Urin Tract Symptoms
Pays: Australia
ID NLM: 101506777

Informations de publication

Date de publication:
Nov 2023
Historique:
revised: 30 06 2023
received: 09 05 2023
accepted: 26 07 2023
medline: 6 11 2023
pubmed: 24 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

We previously demonstrated the efficacy of cognitive behavioral therapy (CBT) using a self-check sheet for patients with nocturia in a randomized controlled study. Additionally, we investigated the efficacy of the intervention in real-world clinical practice. Two hundred forty-three outpatients with complaint of nocturia who practiced CBT for 4 weeks using a self-check sheet were included in this trial, which took place from April 2021 to March 2022 in 20 institutions. Of the 243 patients, 215 who achieved 50% or more of the behavioral therapy tasks were included in the analysis. Their mean age ± SD was 77.1 ± 7.7. A significant decrease was observed in nighttime frequency at 4 weeks after CBT using self-check sheets (pre 3.3 and post 2.8, p < .001). Nighttime frequency was decreased one or more times and was defined as treatment success in 102 patients (47.4%). Pretreatment nighttime frequency in the treatment-success group was significantly higher than that of the failure group (3.5 ± 1.0 vs. 3.2 ± 1.0, p = .013). In multivariate logistic regression analysis, predictive factors of treatment success were pretreatment nocturnal frequency of four or more (odds ratio [OR] 1.82, 95% confidence interval [CI] 1.01-3.30; p = .046) and the absence of diabetes mellitus (OR 3.08, 95% CI 1.34-7.06; p = .008). CBT using a self-check sheet requiring less time, less labor, less cost, and less medication is very beneficial for both patients and medical staff in real-world clinical practice.

Identifiants

pubmed: 37614063
doi: 10.1111/luts.12498
doi:

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

225-230

Informations de copyright

© 2023 John Wiley & Sons Australia, Ltd.

Références

Hashim H, Blanker MH, Drake MJ, et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn. 2019;38(2):499-508.
Kowalik CG, Cohn JA, Delpe S, et al. Nocturia: evaluation and current management strategies. Rev Urol. 2018;20:1-6.
Bosch JL, Weiss JP. The prevalence and causes of nocturia. J Urol. 2013;189:S86-S92.
Bliwise DL, Foley DJ, Vitiello MV, Ansari FP, Ancoli-Israel S, Walsh JK. Nocturia and disturbed sleep in the elderly. Sleep Med. 2009;10:540-548.
Weiss JP, van Kerrebroeck PE, Klein BM, Norgaard JP. Excessive nocturnal urine production is a major contributing factor to the etiology of nocturia. J Urol. 2011;186:1358-1363.
Yap TL, Brown C, Cromwell DA, van der Meulen J, Emberton M. The impact of self-management of lower urinary tract symptoms on frequency-volume chart measures. BJU Int. 2009;104:1104-1108.
Matsuo T, Miyata Y, Sakai H. Effect of salt intake reduction on nocturia in patients with excessive salt intake. Neurourol Urodyn. 2019;38:927-933.
Soda T, Masui K, Okuno H, Terai A, Ogawa O, Yoshimura K. Efficacy of nondrug lifestyle measures for the treatment of nocturia. J Urol. 2010;184(3):1000-1004.
Tani M, Hirayama A, Torimoto K, Matsushita C, Yamada A, Fujimoto K. Guidance on water intake effectively improves urinary frequency in patients with nocturia. Int J Urol. 2014;21:595-600.
Johnson TM 2nd, Markland AD, Goode PS, et al. Efficacy of adding behavioural treatment or antimuscarinic drug therapy to alpha-blocker therapy in men with nocturia. BJU Int. 2013;112:100-108.
Johnson TM 2nd, Vaughan CP, Goode PS, et al. Pilot results from a randomized trial in men comparing alpha-adrenergic antagonist versus behavior and exercise for nocturia and sleep. Clin Ther. 2016;38:2394-2406.e3.
Vaughan CP, Endeshaw Y, Nagamia Z, Ouslander JG, Johnson TM. A multicomponent behavioural and drug intervention for nocturia in elderly men: rationale and pilot results. BJU Int. 2009;104:69-74.
Miller CD, Monaghan TF, Robins DJ, Weiss JP. Does traditional pharmacotherapy augment behavioral modification in the treatment of nocturia? Neurourol Urodyn. 2021;40:1133-1139.
Kyoda Y, Okada M, Kato R, et al. Does cognitive behavioral therapy using a self-check sheet improve night-time frequency in patients with nocturia? Results of a multicenter randomized controlled trial. Int J Urol. 2021;28(4):444-449.
Tikkinen KA, Auvinen A, Johnson TM 2nd, et al. A systematic evaluation of factors associated with nocturia-the population-based FINNO study. Am J Epidemiol. 2009;170:361-368.
Koo MM, Swann R, McPhail S, et al. Presenting symptoms of cancer and stage at diagnosis: evidence from a cross-sectional, population-based study. Lancet Oncol. 2020;21:73-79.
Weiss JP, Monaghan TF, Epstein MR, Lazar JM. Future considerations in nocturia and nocturnal polyuria. Urology. 2019;133S:34-42.
Arlandis S, Bo K, Cobussen-Boekhorst H, et al. European Association of Urology Guidelines on the management of female non-neurogenic lower urinary tract symptoms. Part 2: underactive bladder, bladder outlet obstruction, and nocturia. Eur Urol. 2022;82:60-70.
Presicce F, Puccini F, De Nunzio C, Melchionna A, Lombardo R, Tubaro A. Variations of nighttime and daytime bladder capacity in patients with nocturia: implication for diagnosis and treatment. J Urol. 2019;201:962-966.
Fu Z, Wang F, Dang X, Zhou T. The association between diabetes and nocturia: a systematic review and meta-analysis. Front Public Health. 2022;10:924488.
Mattiasson A, Masala A, Morton R, Bolodeoku J, SOLAR Study Group. Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study. BJU Int. 2010;105:1126-1135.
Burgio KL, Kraus SR, Menefee S, et al. Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial. Ann Intern Med. 2008;149:161-169.

Auteurs

Yuki Kyoda (Y)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Yakumo General Hospital, Yakumo, Japan.
Hokkaido Prefectural Haboro Hospital, Haboro, Japan.
Rumoi Municipal Hospital, Rumoi, Japan.

Koji Ichihara (K)

Sapporo Central Hospital, Sapporo, Japan.

Ippei Muranaka (I)

Hokkaido Social Work Association Obihiro Hospital, Obihiro, Japan.

Yasuyuki Sakai (Y)

Takikawa Municipal Hospital, Takikawa, Japan.

Makoto Nakamura (M)

Muroran City General Hospital, Muroran, Japan.

Nobuo Shinkai (N)

Saiseikai Otaru Hospital, Otaru, Japan.

Nodoka Kozen (N)

JCHO Hokkaido Medical Center, Sapporo, Japan.

Wakako Yorozuya (W)

Kushiro Red Cross Hospital, Kushiro, Japan.

Daichi Morooka (D)

Asahikawa Red Cross Hospital, Asahikawa, Japan.

Kazutaka Maruo (K)

Hokkaido Medical Center, Sapporo, Japan.

Kimihito Tachikawa (K)

Hakodate Goryoukaku Hospital, Hakodate, Japan.

Kosuke Shibamori (K)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Kuriyama Red Cross Hospital, Kuriyama, Japan.
Hokkaido Social Work Association Toya Hospital, Toyako, Japan.
JCHO Noboribetsu Medical Center, Noboribetsu, Japan.

Seisuke Nofuji (S)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Kuriyama Red Cross Hospital, Kuriyama, Japan.
Hokkaido Social Work Association Toya Hospital, Toyako, Japan.
JCHO Noboribetsu Medical Center, Noboribetsu, Japan.

Keiko Fujino (K)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Kuriyama Red Cross Hospital, Kuriyama, Japan.
Hokkaido Social Work Association Toya Hospital, Toyako, Japan.
JCHO Noboribetsu Medical Center, Noboribetsu, Japan.

Shuichi Kato (S)

Oji General Hospital, Tomakomai, Japan.

Takashi Yoshida (T)

NTT-East Sapporo Hospital, Sapporo, Japan.

Tetsuya Shindo (T)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Takeshi Maehana (T)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Kohei Hashimoto (K)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Ko Kobayashi (K)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.
Nemuro City Hospital, Nemuro, Japan.

Toshiaki Tanaka (T)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Naoya Masumori (N)

Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH